Matthew John Wakefield

Matthew John Wakefield

Auto-generated profile, based on publicly available information

Matthew John Wakefield

Walter and Eliza Hall Institute of Medical Research, Parkville, Australia

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 February 2010 in Genome Biology
Verified
Journal Article
Open access
PDF file
MYMatthew D Young
Matthew D Young
MWMatthew J Wakefield
Matthew J Wakefield
GSGordon Smyth
Gordon Smyth
AOAlicia Oshlack
Alicia Oshlack
We present GOseq, an application for performing Gene Ontology (GO) analysis on RNA-seq data. GO analysis is widely used to reduce complexity and highlight biological processes in genome-wide expression studies, but standard methods give biased results on RNA-seq data due to over-detection of differential expression for long and highly expressed transcripts. Application of GOseq to a prostate cancer data set shows that GOseq dramatically changes the results, highlighting categories more consistent with the known biology.

1 May 2007 in Nature
Verified
Journal Article
Closed access
PDF file
BPBroad Institute Genome Sequencing Platform
Broad Institute Genome Sequencing Platform
TMTarjei S. Mikkelsen
Tarjei S. Mikkelsen
BTBroad Institute Whole Genome Assembly Team
Broad Institute Whole Genome Assembly Team
MWMatthew J. Wakefield
Matthew J. Wakefield
BABronwen Aken
Bronwen Aken
KLKerstin Lindblad-Toh
Kerstin Lindblad-Toh

8 May 2008 in Nature
Verified
Journal Article
Open access
PDF file
WWWesley C Warren
Wesley C Warren
LHLaDeana W Hillier
LaDeana W Hillier
JGJennifer Graves
Jennifer Graves
EBEwan Birney
Ewan Birney
CPChris P Ponting
Chris P Ponting
RWRichard K Wilson
Richard K Wilson
We present a draft genome sequence of the platypus, Ornithorhynchus anatinus. This monotreme exhibits a fascinating combination of reptilian and mammalian characters. For example, platypuses have a coat of fur adapted to an aquatic lifestyle; platypus females lactate, yet lay eggs; and males are equipped with venom similar to that of reptiles. Analysis of the first monotreme genome aligned these features with genetic innovations. We find that reptile and platypus venom proteins have been co-opted independently from the same gene families; milk protein genes are conserved despite platypuses laying eggs; and immune gene family expansions are directly related to platypus biology. Expansions of protein, non-protein-coding RNA and microRNA families, as well as repeat elements, are identified. Sequencing of this genome now provides a valuable resource for deep mammalian comparative analyses, as well as for monotreme biology and conservation.

5 January 2004 in BMC Bioinformatics
Verified
Journal Article
Open access
PDF file
ABAndrew Butterfield
Andrew Butterfield
VVVivek Vedagiri
Vivek Vedagiri
ELEdward Lang
Edward Lang
CLCath Lawrence
Cath Lawrence
MWMatthew J Wakefield
Matthew J Wakefield
GHGavin A Huttley
Gavin A Huttley
Examining the distribution of variation has proven an extremely profitable technique in the effort to identify sequences of biological significance. Most approaches in the field, however, evaluate only the conserved portions of sequences – ignoring the biological significance of sequence differences. A suite of sophisticated likelihood based statistical models from the field of molecular evolution provides the basis for extracting the information from the full distribution of sequence variation. The number of different problems to which phylogeny-based maximum likelihood calculations can be applied is extensive. Available software packages that can perform likelihood calculations suffer from a lack of flexibility and scalability, or employ error-prone approaches to model parameterisation. Here we describe the implementation of PyEvolve, a toolkit for the application of existing, and development of new, statistical methods for molecular evolution. We present the object architecture and design schema of PyEvolve, which includes an adaptable multi-level parallelisation schema. The approach for defining new methods is illustrated by implementing a novel dinucleotide model of substitution that includes a parameter for mutation of methylated CpG's, which required 8 lines of standard Python code to define. Benchmarking was performed using either a dinucleotide or codon substitution model applied to an alignment of BRCA1 sequences from 20 mammals, or a 10 species subset. Up to five-fold parallel performance gains over serial were recorded. Compared to leading alternative software, PyEvolve exhibited significantly better real world performance for parameter rich models with a large data set, reducing the time required for optimisation from ~10 days to ~6 hours. PyEvolve provides flexible functionality that can be used either for statistical modelling of molecular evolution, or the development of new methods in the field. The toolkit can be used interactively or by writing and executing scripts. The toolkit uses efficient processes for specifying the parameterisation of statistical models, and implements numerous optimisations that make highly parameter rich likelihood functions solvable within hours on multi-cpu hardware. PyEvolve can be readily adapted in response to changing computational demands and hardware configurations to maximise performance. PyEvolve is released under the GPL and can be downloaded from http://cbis.anu.edu.au/software .

1 January 2009 in Biology Direct
Verified
Journal Article
Open access
PDF file
AOAlicia Oshlack
Alicia Oshlack
MWMatthew J Wakefield
Matthew J Wakefield
Several recent studies have demonstrated the effectiveness of deep sequencing for transcriptome analysis (RNA-seq) in mammals. As RNA-seq becomes more affordable, whole genome transcriptional profiling is likely to become the platform of choice for species with good genomic sequences. As yet, a rigorous analysis methodology has not been developed and we are still in the stages of exploring the features of the data.

31 August 2017 in Cancer Discovery
Verified
Journal Article
Open access
PDF file
OKOlga Kondrashova
Olga Kondrashova
MNMinh Nguyen
Minh Nguyen
KSKristy Shield-Artin
Kristy Shield-Artin
ATAnna V. Tinker
Anna V. Tinker
NTNelson N.H. Teng
Nelson N.H. Teng
CSClare L Scott
Clare L Scott
High-grade epithelial ovarian carcinomas containing mutated BRCA1 or BRCA2 (BRCA1/2) homologous recombination (HR) genes are sensitive to platinum-based chemotherapy and PARP inhibitors (PARPi), while restoration of HR function due to secondary mutations in BRCA1/2 has been recognized as an important resistance mechanism. We sequenced core HR pathway genes in 12 pairs of pretreatment and postprogression tumor biopsy samples collected from patients in ARIEL2 Part 1, a phase II study of the PARPi rucaparib as treatment for platinum-sensitive, relapsed ovarian carcinoma. In 6 of 12 pretreatment biopsies, a truncation mutation in BRCA1, RAD51C, or RAD51D was identified. In five of six paired postprogression biopsies, one or more secondary mutations restored the open reading frame. Four distinct secondary mutations and spatial heterogeneity were observed for RAD51C. In vitro complementation assays and a patient-derived xenograft, as well as predictive molecular modeling, confirmed that resistance to rucaparib was associated with secondary mutations. Significance: Analyses of primary and secondary mutations in RAD51C and RAD51D provide evidence for these primary mutations in conferring PARPi sensitivity and secondary mutations as a mechanism of acquired PARPi resistance. PARPi resistance due to secondary mutations underpins the need for early delivery of PARPi therapy and for combination strategies. Cancer Discov; 7(9); 984–98. ©2017 AACR. See related commentary by Domchek, p. 937. See related article by Quigley et al., p. 999. See related article by Goodall et al., p. 1006. This article is highlighted in the In This Issue feature, p. 920